Neutralizing Antibodies Current Events | Neutralizing Antibodies News
|
| Page
1 of
19 |
372 Results |
|
|
|
Sort By:
Page Views | Date |
NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
Most vaccines that protect against viruses generate infection-fighting proteins called antibodies that either block infection or help eliminate the virus before it can cause disease. view more (2009-06-15)
New technology opens gateway to studying HIV-specific neutralizing antibodies
Many scientists believe a vaccine that prevents HIV infection will need to stimulate the body to make neutralizing antibodies, infection-fighting proteins that prevent HIV from entering immune cells. view more (2009-03-16)
New study suggests potential for a broadly-protective HIV vaccine
New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus. view more (2007-05-30)
Researchers induce HIV-neutralizing antibodies that recognize HIV-1 envelope protein, lipids
For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids. view more (2009-09-02)
Study offers insights into failed HIV-1 vaccine trial
Following the disbandment of the STEP trial to test the efficacy of the Merck HIV-1 vaccine candidate in 2007, the leading explanation for why the vaccine was ineffective - and may have even increased susceptibility to acquiring the virus - centered on the hypothesis that high levels of baseline Ad5-specific neutralizing antibodies may have... view more... (2009-07-21)
HIV uses several strategies to escape immune pressure
A study of how HIV mutates in response to immune system pressure by Emory Vaccine Center researchers shows that the virus can take several escape routes, not one preferred route. view more (2009-09-21)
Penn-Wistar team gains insight into HIV vaccine failure
A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1 vaccines. view more (2009-07-21)
New findings suggest strategy to help generate HIV-neutralizing antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. view more (2009-11-20)
Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design
A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine. view more (2009-11-10)
A natural approach for HIV vaccine
For 25 years, researchers have tried and failed to develop an HIV vaccine, primarily by focusing on a small number of engineered "super antibodies" to fend off the virus before it takes hold. view more (2009-03-16)
Survivors of 1918 flu pandemic protected with a lifetime immunity to virus
New research has discovered that infection and natural exposure to the 1918 influenza virus made survivors immune to the disease for the remaining of their lives. view more (2008-08-18)
Uncovering the Achilles' heel of the HIV-1 envelope
New structural details illustrate how a promising class of antibodies may block human immunodeficiency virus (HIV)-1 infection and reveal valuable clues for design of an effective HIV-1 vaccine. view more (2008-01-14)
Scientists unveil piece of HIV protein that may be key to AIDS vaccine development
In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an... view more... (2007-02-15)
Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection
Some 25 years after the AIDS epidemic spawned a worldwide search for an effective vaccine against the human immunodeficiency virus (HIV), progress in the field seems to have effectively become stalled. view more (2009-04-23)
Reactor of the future destroys nuclear waste--KTH to head major EU project to cut storage times dramatically
A power plant that generates energy from used nuclear waste and destroys it as well. Could this become a reality? A three-year research project involving 23 European partners coordinated by KTH is being launched to investigate the matter. In the last few years great strides have been taken in research into so-called transmutation (see footnote)... view more... (2004-03-18)
Antibodies can halve risk of transplant rejection
Giving interleukin-2 receptor antibodies to patients after a kidney transplant can halve the risk of rejection, concludes a study in this week's BMJ. Researchers in Birmingham reviewed eight trials of interleukin-2 receptor antibodies versus placebo in 1,858 patients receiving standard immunosuppressant drugs after kidney transplants. Treatment... view more... (2003-04-10)
Detection Of Antibodies Could Identify MS Patients Who Do Not Respond Well To Interferon Beta (P1184)
Danish research published in this week's issue of THE LANCET highlights how the detection of antibodies to interferon beta-the first choice treatment for multiple sclerosis patients-could be important in identifying patients who do not respond well to interferon beta, with implications for the provision of alternative drug therapy. Interferon beta... view more... (2003-10-08)
Researchers link specific antibody presence to prevention of mother-to-baby HIV transmission
Exploring why some HIV-positive mothers transmit the virus in utero to their babies while others don't, researchers from the UCLA AIDS Institute and Los Alamos National Laboratory studied 38 infant-mother pairs in the UCLA arm of the Los Angeles Pediatric AIDS Consortium. view more (2006-07-12)
Autoantibodies common in anorexia patients
A large proportion of anorexia and/or bulimia patients have antibodies against the body's own substances that are involved in the brain's control of eating behavior. The results indicate that there is a connection between eating disturbances and both the nervous system and the immune system. The study was based on 57 women, between the ages of 17... view more... (2002-12-12)
Experimental vaccine protects mice against deadly 1918 flu virus
Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. view more (2006-10-18)
|
|
| Page
1 of
19 |
372 Results |
|
|
|
Sort By:
Page Views | Date |
|
